Related content

Randomized, Single-Blind, Placebo-Controlled Multicenter Trial to Compare the Efficacy and Safety of Metronidazole and Satranidazole in Patients With Amebic Liver Abscess

By Muzaffar Jameel   Madan Kaushal   Sharma M.   Kar Premashish  

Digestive Diseases and Sciences, Vol. 51, Iss. 12, 2006-12 ,pp. : 2270-2273

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial

By Maria Morais-Socorro   Alvaro Cavalcanti Maciel   Rand Martins   Paulo Neto Francisco   Adriana Rezende   George Azevedo   Maria Almeida  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 483-487

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of atorvastatin and pravastatin in patients with hypercholesterolemia

By Assmann G.   Huwel D.   Schussman K.-M.   Smilde J.G.   Kosling M.   Withagen A.J.A.M.   Wunderlich J.   Stoel I.   van Dormaal J.J.   Neuss J.   Oldenbroek C.   Cuppers M.C.   von Eckardstein A.   Schulte H.   Wagner B.   McLain R.   Black D.M.  

European Journal of Internal Medicine, Vol. 10, Iss. 1, 1999-05 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite